人类免疫缺陷病毒(HIV)
抗药性
病毒学
抗逆转录病毒疗法
医学
病毒载量
内科学
人口学
生物
遗传学
社会学
作者
Xiu Liu,Dong Wang,Jing Hu,Chang Song,Lingjie Liao,Yi Feng,Dan Li,Hui Xing,Yuhua Ruan
出处
期刊:China CDC weekly
[Chinese Center for Disease Control and Prevention]
日期:2023-01-01
卷期号:5 (30): 664-671
被引量:50
标识
DOI:10.46234/ccdcw2023.129
摘要
The total prevalence of TDR in China has achieved a moderate level (7.8%) from 2020 to 2022, with NNRTI resistance standing prominently at 6.7%. Consequently, measures to curb TDR are urgently required, particularly among ART-naïve HIV-infected individuals in China.
科研通智能强力驱动
Strongly Powered by AbleSci AI